for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Abbott Laboratories

abt

Latest Trade

82.38USD

Change

--(--)

Today's Range

--

 - 

--

52 Week Range

65.44

 - 

88.76

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
82.38
Open
--
Volume
--
3M AVG Volume
98.78
Today's High
--
Today's Low
--
52 Week High
88.76
52 Week Low
65.44
Shares Out (MIL)
1,767.40
Market Cap (MIL)
144,537.80
Forward P/E
25.22
Dividend (Yield %)
1.57

Latest Developments

More

Abbott Reports Third-Quarter 2019 Results

Abbott Laboratories - On October 11, Board Authorized Repurchase Of Up To $3 Billion Of Abbott Shares

Omada Health Says Co, Abbott To Integrate Abbott's Freestyle Libre System With Co's Digital Care Program

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Abbott Laboratories

Abbott Laboratories is engaged in the discovery, development, manufacture and sale of a range of healthcare products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products and Vascular Products. Its Established Pharmaceutical Products include a range of branded generic pharmaceuticals manufactured around the world and marketed and sold outside the United States. Its Diagnostic Products include a range of diagnostic systems and tests. Its Nutritional Products include a range of pediatric and adult nutritional products. Its Company's Vascular Products include a range of coronary, endovascular, vessel closure and structural heart devices for the treatment of vascular disease. The Company, through St. Jude Medical, Inc., also offers products, such as rhythm management products, electrophysiology products, heart failure related products, vascular products, structural heart products and neuromodulation products.

Industry

Medical Equipment & Supplies

Contact Info

100 Abbott Park Rd

+1.224.6676100

http://www.abbott.com

Executive Leadership

Miles D. White

Chairman of the Board, Chief Executive Officer

Robert B. Ford

President, Chief Operating Officer

Brian B. Yoor

Chief Financial Officer, Executive Vice President - Finance

Hubert L. Allen

Executive Vice President, General Counsel, Secretary

Jaime Contreras

Senior Vice President - Core Laboratory Diagnostics, Commercial Operations

Key Stats

1.68 mean rating - 19 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2016

20.9K

2017

27.4K

2018

30.6K

2019(E)

31.9K
EPS (USD)

2016

2.200

2017

2.500

2018

2.880

2019(E)

3.243
Price To Earnings (TTM)
44.21
Price To Sales (TTM)
4.61
Price To Book (MRQ)
--
Price To Cash Flow (TTM)
23.92
Total Debt To Equity (MRQ)
--
LT Debt To Equity (MRQ)
--
Return on Investment (TTM)
--
Return on Equity (TTM)
--

Latest News

Latest News

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up